How to Decide Exactly Where to Get Fillers and Botox
Your forehead isn't the only spot you can get an injectable. Here's what you need to know about filler and Botox injection sites — both well-established and newly available, according to Shape.
Tag: botox
All
Popular
All
Latest
New Short-Term Botox-Like Treatment Moves Closer to FDA Review
The neurotoxin is characterized by a rapid onset of action as early as eight hours after administration and a shorter duration of effect of two to three weeks.
All
Latest
Integrating GLP-1s into Aesthetic Practice: Dr Johnny Franco on Personalizing the Patient Journey
Plastic surgeon Johnny Franco, MD, discusses how his firsthand experience with GLP-1s shaped his patient-centered wellness program and what plastic surgeons should know before adding similar treatments to their aesthetic practices.
BOTOX Cosmetic Names Winners of the IFundWomen Grant Program
Allergan Aesthetics announces the 20 women entrepreneurs who will receive funding and mentorship through the BOTOX Cosmetic and IFundWomen grant program, which aims to support women-owned businesses and address the so-called “confidence gap” in translating ideas into successful ventures.
Read More
AI Tool Predicts Which patients with Dystonia Respond to Botox Treatment
An artificial intelligence tool called DystoniaBoTXNet predicted which patients with dystonia would benefit from botulinum toxin injections with 96.3% accuracy.
Read More
Post Hoc Analysis Evaluates Efficacy of Jeuveau in Adult Males Compared to Botox
Evolus Inc. announces that a peer-reviewed, post-hoc analysis showed with high consistency that males treated with Jeuveau, the company’s neurotoxin product, had higher responder rates than those treated with Botox.
Read More
Allergan Celebrates 20 Years of Botox
Allergan Aesthetics is celebrating Botox’s 20th anniversary as an FDA-approved product with a cross-country art installation.
Read More
Aquavit Files Investigation of New Drug for New Botulinum Toxin
Aquavit Pharmaceuticals, Inc. has submitted to the U.S. FDA an Investigation of New Drug package for a new botulinum toxin, DTX-021.
Read More
UK Plans to Require Licensing for Administration of Botox and Dermal Fillers
The latest legislation follows a law enacted in England last fall that prohibits those under 18 from receiving Botox or dermal lip fillers for cosmetic reasons.
Read More
21-Year-Old Warns Against Botox After Botched Injections Left Her with a Crooked Smile and a Lisp
A woman has warned against Botox injections after the toxin migrated to the side of her face, leaving her with both a crooked smile and a lisp, the Daily Mail reports.
Read More
6 Post-Botox Mistakes Way Too Many People Are Making
InStyle talked to two board-certified dermatologists to compile a list of things you shouldn’t do, and others you shouldn’t worry about. Here’s what you need to know.
Read More
Over 40 Camels Disqualified From Beauty Contest in Saudi Arabia For Receiving Botox Injections
It wasn’t a happy Hump Day for some camel breeders in Saudi Arabia, People reports.
Read More
Botox While Breastfeeding: Here’s What You Need To Know
If debating to get Botox while breastfeeding, there are things to know, BabyGaga reports.
Read More
Forget Botox and Fillers: Why Full-On Facelifts Are Hotter Than Ever
Knives out: Both men and women are seeking facelift surgery to undo their “filler faces,” New York Post reports.
Read More
The Uses Of Botox Beyond Wrinkles
A Haute Beauty expert explains the uses of botox beyond wrinkles.
Read More
When Can You Work Out After Botox?
Botox treatments and exercise can be a bad mix. Shape advises how long (and why) you should wait before resuming your workout routine.
Read More
Xeomin vs. Botox: What’s the Difference Between These Two Wrinkle Fighters?
PureWow explains the similarities and differences between Xeomin and Botox, and how to choose between the two.
Read More
AbbVie’s Botox Patent Lawsuit is ‘Very Unlikely to Derail’ Revance’s Rival Launch: Analysts
For a small company seeking to market a rival to a dominant brand, a patent lawsuit from a global pharma giant would seem to be a cause for concern. But Revance has a good chance of beating back AbbVie’s recent patent case, one team of analysts figures, Fierce Pharma reports.
Read More